FLORHAM PARK, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel…
Acquisition of Cleared Further Diversifies LifeMD’s Telehealth Offerings to Encompass Allergy, Asthma, and Immunology Acquisition Expected to Synergize with LifeMD Virtual…
In business for 20 years, Body Energy Club is the leading health supplement and vitamin retailer in Western Canada, with…
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive DisorderBURLINGTON, Mass. and JERUSALEM, Israel,…
nVNS reduces symptoms of PTSD by 31% in sham-controlled studyROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR),…
BURNABY, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that…
MIAMI, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company…
IMX-110 Surpasses Standard of Care in Mice Cancer Study Immix Biopharma, Inc. (NASDAQ:IMMX) IMX-110 produced a 50% response rate after…
Data demonstrates that PTX-35 may have utility in solid organ transplantation, and to potentially slow or mitigate deleterious immune responses…
EDISON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- It is with profound sadness that Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) announces the…